7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
                       
      cash flows from operating activities
                       
      net income
    -24,465,000 -7,298,000 -14,817,000 -26,137,000 -16,029,000 -17,063,000 -20,471,000 -23,241,000 -18,238,000 -15,582,000 -18,200,000 -24,515,000 -23,668,000 -24,515,000 -29,495,000 -26,312,000 -24,803,000 -9,692,000 -17,375,000 
      adjustments to reconcile net income to net cash from operating activities:
                       
      depreciation and amortization
    10,977,000 10,902,000 10,547,000 10,357,000 9,769,000 8,880,000 7,802,000 6,878,000 5,087,000 3,928,000 3,392,000 3,168,000 3,109,000 2,586,000 2,515,000 2,532,000 2,493,000 1,837,000 1,891,000 
      stock-based compensation expense, net of amounts capitalized
    11,303,000 15,454,000 16,574,000 19,955,000 18,261,000 14,964,000 14,830,000 13,386,000 12,855,000 11,902,000 11,505,000 13,437,000 9,594,000 8,744,000 7,549,000     
      benefit from bad debt
    26,221,000 1,508,000 1,603,000 1,828,000 3,106,000 2,958,000 2,097,000 2,393,000 2,723,000 3,631,000 2,176,000 3,947,000 3,001,000 2,307,000 1,793,000 2,445,000 929,000 812,000 777,000 
      other non-cash
    -97,000 1,562,000 704,000 372,000 250,000 -237,000 356,000 -692,000 -197,000 -273,000 -302,000 -382,000 -81,000 -253,000 659,000 151,000 30,000 310,000 165,000 
      changes in operating assets and liabilities, net of effects from purchases of businesses:
                       
      trade receivables
    -9,924,000 34,000,000 -75,714,000 34,269,000 2,355,000 14,518,000 -33,676,000 3,416,000 -16,112,000 48,589,000 -21,487,000 -17,156,000 70,480,000 449,000 -6,603,000 -8,202,000 19,526,000 -46,343,000 -85,136,000 
      other operating assets
    -14,167,000 1,557,000 -2,616,000 1,744,000 -5,204,000 3,325,000 -289,000 4,956,000 -6,888,000 2,463,000 -841,000         
      accounts payable
    6,420,000 -37,411,000 122,834,000 -39,517,000 18,043,000 -30,576,000 68,217,000 -32,069,000 6,532,000 -71,836,000 62,761,000 25,298,000 -58,910,000 -31,949,000 -7,526,000 19,346,000 8,224,000 76,856,000 138,430,000 
      other operating liabilities
    3,985,000 -6,559,000 7,509,000 -6,090,000 -9,426,000 7,747,000 4,109,000 -1,523,000 -507,000 -2,446,000 3,976,000         
      net cash from operating activities
    10,253,000 13,715,000 66,624,000 -3,219,000 21,125,000 4,516,000 42,975,000 -26,496,000 -14,745,000 -19,624,000 42,980,000 134,000 -2,757,000 -41,096,000 -31,456,000 -3,127,000 15,603,000 26,950,000 45,864,000 
      capex
    -2,777,000 -3,102,000 144,000 -705,000 -1,253,000 -1,739,000 44,000 -1,044,000 -1,241,000 -1,287,000 2,287,000 -729,000 270,000 -1,837,000 316,000 -195,000 -981,000 -972,000 -98,000 
      free cash flows
    7,476,000 10,613,000 66,768,000 -3,924,000 19,872,000 2,777,000 43,019,000 -27,540,000 -15,986,000 -20,911,000 45,267,000 -595,000 -2,487,000 -42,933,000 -31,140,000 -3,322,000 14,622,000 25,978,000 45,766,000 
      cash flows from investing activities
                       
      net increase in finance receivables
    -15,530,000 -54,288,000 -17,276,000 -9,469,000 -10,685,000 -804,000 -1,047,000 -14,282,000 -8,726,000 5,142,000 -27,407,000 -5,851,000 1,761,000 -14,472,000 -19,420,000 -9,984,000 -8,819,000 -10,583,000 -7,570,000 
      purchases of property and equipment
    -2,602,000 -2,859,000 -1,346,000 -705,000 -962,000 -1,797,000 -1,075,000 -812,000 -638,000 -614,000 -266,000 -559,000 -843,000 -1,061,000 -748,000 -372,000 -533,000 -972,000 -692,000 
      proceeds from sale of real estate
                      
      capitalization of software costs
    -8,904,000 -9,201,000 -8,731,000 -7,264,000 -7,583,000 -7,342,000 -7,513,000 -6,521,000 -6,493,000 -7,883,000 -4,943,000 -6,040,000 -5,456,000 -4,747,000 -3,942,000 -2,914,000 -3,949,000 -2,301,000 -2,296,000 
      purchases of marketable securities
    -4,088,000 -14,680,000 -10,153,000 -14,372,000 -18,705,000 -2,902,000 -29,996,000 -27,978,000 -52,456,000 -35,602,000 -51,972,000 -20,394,000 -189,901,000 -7,411,000     
      maturities and redemptions of marketable securities
    18,250,000 6,638,000 3,500,000 15,465,000 39,669,000 30,030,000 28,034,000 33,200,000 32,540,000 41,950,000 45,774,000 19,216,000       
      sales of marketable securities
       7,392,000 52,678,000 70,020,000 -247,000 247,000 2,402,000         
      acquisition of businesses
       133,000 -1,399,000 -46,756,000 -108,453,000 -974,000 -16,649,000   -18,913,000 -4,569,000    
      net cash from investing activities
    -31,124,000 -62,778,000 -30,868,000 -28,177,000 16,311,000 16,943,000 -20,940,000 -24,798,000 -27,037,000 -35,271,000 -23,866,000 -18,648,000 -5,716,000 -208,181,000 -50,434,000 -31,620,000 -73,232,000 -13,856,000 -10,558,000 
      cash flows from financing activities
                       
      proceeds from long term debt
    133,500,000 120,000,000 100,000,000 36,500,000 115,000,000 150,000,000 190,000,000 115,000,000 105,000,000 105,000,000 95,000,000 75,000,000 70,000,000 70,000,000 60,000,000 3,500,000 1,750,000 
      payments towards long term debt
    -100,000,000 -100,000,000 -56,500,000 -28,500,000 -110,000,000 -165,000,000 -180,000,000 -105,000,000 -105,000,000 -95,500,000 -75,000,000 -70,000,000 -70,000,000     
      payment of debt issuance costs
    -33,000    -264,000               
      proceeds from exercise of stock options
    229,000 149,000 382,000 792,000 1,832,000 4,411,000 2,401,000 689,000 802,000 1,875,000 899,000 211,000 240,000 348,000 411,000     
      payment of rsu tax withholdings in exchange for common shares surrendered by rsu holders
    -5,854,000 -5,828,000 -11,808,000 -7,594,000 -6,427,000 -6,020,000 -7,090,000 -4,745,000 -4,645,000 -3,016,000 -3,619,000 -1,983,000 -919,000 -1,282,000 -1,274,000 -1,439,000    
      proceeds from employee stock purchase plan
      1,912,000   1,732,000   1,251,000       
      other financing activities
    -25,000 -32,000 -42,000 -43,000 -23,000 -95,000            
      net cash from financing activities
    27,817,000 15,366,000 32,032,000 3,053,000 98,000 -16,313,000 5,288,000 7,581,000 -3,917,000 9,689,000 17,280,000 4,479,000 -679,000 9,996,000 59,137,000 -910,000 -5,044,000 -8,458,000 390,657,000 
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    32,000 177,000 32,000 -116,000 18,000 -19,000 -49,000 48,000 -12,000 4,000 3,000 12,000 -15,000 -26,000 8,000     
      net increase in cash, cash equivalents, and restricted cash
    6,978,000 -33,520,000 67,820,000 -28,459,000 37,552,000 5,127,000 27,274,000 -43,665,000 -45,711,000 -45,202,000 36,397,000 -14,023,000 -9,167,000 -239,307,000 -22,745,000     
      cash, cash equivalents, and restricted cash, beginning of period
    224,065,000 182,571,000 280,752,000 565,994,000     
      cash, cash equivalents, and restricted cash, end of period
    6,978,000 -33,520,000 291,885,000 -28,459,000 37,552,000 5,127,000 209,845,000 -43,665,000 -45,711,000 -45,202,000 317,149,000 -14,023,000 -9,167,000 -239,307,000 543,249,000     
      supplemental disclosure of cash flow information
                       
      non-cash investing and financing activities:
                       
      stock-based compensation included in capitalized software development costs
    2,061,000 1,770,000 1,843,000 1,647,000 1,615,000 1,070,000 1,184,000 989,000 911,000 787,000 696,000 615,000 648,000 375,000 375,000     
      purchase of property and equipment and internal use software in accounts payable
    -175,000 -243,000 1,490,000  -291,000 58,000 1,119,000 -232,000 -603,000 -673,000 2,553,000 -170,000 1,113,000 -776,000 1,064,000 177,000 -448,000   
      payments for debt issuance and other financing costs
                      
      cash paid during the period for:
                       
      interest expense
                      74,000 
      income taxes
               54,000 35,000 283,000 16,000 51,000 98,000 122,000 -10,000 
      proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other offering costs
                   -2,000 -114,000 -2,507,000 388,359,000 
      payments towards promissory note
                      
      (gain) on contingent liabilities
                       
      other current assets
               4,545,000 -4,062,000 5,222,000 -5,356,000 1,840,000 322,000 596,000 -4,805,000 
      accrued interest on marketable securities
                       
      accrued payroll
               -5,708,000 25,000 740,000 -1,057,000 -1,024,000 52,000 458,000 3,750,000 
      accrued other liabilities
               -1,105,000 -643,000 -4,147,000 5,042,000 950,000 -14,000 -1,546,000 3,078,000 
      other long-term liabilities
               -896,000 132,000 114,000 99,000 -1,390,000 -238,000 83,000 80,000 
      other assets
               -133,000 20,000 -132,000 -77,000 -182,000 -210,000 -82,000 -136,000 
      proceeds from issuance of series e1 preferred stock
                       
      cash paid (received) during the period for:
                       
      interest income
               -1,926,000 -1,429,000 -264,000 63,000 -124,000 337,000   
      cash paid included in the measurement of operating lease liabilities
               478,000 362,000 363,000 299,000    219,000 
      deferred revenue
                -1,754,000 -262,000 1,001,000 -93,000 -492,000 -99,000 2,281,000 
      stock issuance costs in accounts payable
                     -2,533,000 2,673,000 
      proceeds from issuance of series d preferred stock
                       
      proceeds from issuance of series e preferred stock
                       
      right-of-use assets obtained, including initial adoption
                       
      contingent consideration
                       
      stock-based compensation expense
                    9,787,000 3,763,000 2,867,000 
      non-cash operating lease costs
                    -3,000 -3,000 -3,000 
      proceeds from exercise of common stock options
                    421,000 131,000 548,000 
      net increase in cash and cash equivalents
                    -62,673,000 4,636,000 425,963,000 
      cash and cash equivalents, beginning of period
                    233,725,000 
      cash and cash equivalents, end of period
                    -62,673,000 4,636,000 659,688,000 
      purchase of property and equipment in accounts payable
                      594,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.